Calithera Biosciences Inc
NASDAQ:CALA
Calithera Biosciences Inc
Accrued Liabilities
Calithera Biosciences Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Calithera Biosciences Inc
NASDAQ:CALA
|
Accrued Liabilities
$6.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accrued Liabilities
$5.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Accrued Liabilities
$14.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
28%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
See Also
What is Calithera Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
6.7m
USD
Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Accrued Liabilities amounts to 6.7m USD.
What is Calithera Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-6%
Over the last year, the Accrued Liabilities growth was -36%. The average annual Accrued Liabilities growth rates for Calithera Biosciences Inc have been -28% over the past three years , -6% over the past five years .